NCT05638841 Prospective Cohort Study of the Risk of Recurrent Atrial Fibrillation After Radiofrequency Ablation
| NCT ID | NCT05638841 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Peking University Third Hospital |
| Condition | Atrial Fibrillation |
| Study Type | OBSERVATIONAL |
| Enrollment | 300 participants |
| Start Date | 2023-01-01 |
| Primary Completion | 2024-12-31 |
Trial Parameters
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
In this study, the continuous inclusion of atrial fibrillation patients treated by catheter ablation in the Department of Cardiology, Peking University Third Hospital, through the collection of clinical data and outpatient follow-up, to explore the risk factors of atrial fibrillation recurrence after catheter ablation and the influencing factors of major clinical events in atrial fibrillation patients, and further guide the management mode of atrial fibrillation patients.
Eligibility Criteria
Inclusion Criteria: * 1\) Age \> 18 * 2\) ECG or holter electrocardiogram confirmed atrial fibrillation Exclusion Criteria: * 1\) Hematological diseases, autoimmune diseases and malignant tumors * 2\) Immobility caused by hemiplegia or severe trauma * 3\) The expected survival time is less than 2 years * 4\) Poor compliance and high risk of expected loss of follow-up * 5\) Disorders of consciousness or Alzheimer's disease
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.